APO Research
Talk to an analyst

APO RESEARCH · REPORT

Estrogen

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Estrogen Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchEstrogen Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Estrogen Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Estrogen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estrogen Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Estrogen Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Estrogen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Estrogen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Estrogen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Estrogen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Estrogen market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Estrogen market include Teva Pharmaceuticals, Pfizer, Bayer and Xi'an Sgonek Biological Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Estrogen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Estrogen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Estrogen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Estrogen market size, projected growth trends, production technologies, key applications, and end-use industries.

Estrogen Segment by Company

Teva Pharmaceuticals

Pfizer

Bayer

Xi'an Sgonek Biological Technology

Estrogen Segment by Type

Tablets

Injection

Estrogen Segment by Application

Hospitals

Obstetrics & Gynecology Clinics

Others

Estrogen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Estrogen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Estrogen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Estrogen significant trends, drivers, influence factors in global and regions.

6. To analyze Estrogen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estrogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estrogen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estrogen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Estrogen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Estrogen industry.

Chapter 3: Detailed analysis of Estrogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Estrogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Estrogen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Estrogen Industry Trends Table 2. Estrogen Industry Drivers Table 3. Estrogen Industry Opportunities and Challenges Table 4. Estrogen Industry Restraints Table 5. Global Estrogen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Estrogen Revenue Share by Company (2021-2026) Table 7. Global Estrogen Sales Volume by Company (k units) & (2021-2026) Table 8. Global Estrogen Sales Volume Share by Company (2021-2026) Table 9. Global Estrogen Average Price (US$/unit) of Company (2021-2026) Table 10. Global Estrogen Company Ranking, (2024-2026) & (USD Million) Table 11. Global Estrogen Key Company Manufacturing Base & Headquarters Table 12. Global Estrogen Company, Product Type & Application Table 13. Global Estrogen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Estrogen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Injection Table 19. Global Estrogen Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Estrogen Sales Volume by Type (2021-2026) & (k units) Table 21. Global Estrogen Sales Volume by Type (2027-2032) & (k units) Table 22. Global Estrogen Sales Volume Share by Type (2021-2026) Table 23. Global Estrogen Sales Volume Share by Type (2027-2032) Table 24. Global Estrogen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Estrogen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Estrogen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Estrogen Sales Value Share by Type (2021-2026) Table 28. Global Estrogen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Obstetrics & Gynecology Clinics Table 31. Significant Companies of Others Table 32. Global Estrogen Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Estrogen Sales Volume by Application (2021-2026) & (k units) Table 34. Global Estrogen Sales Volume by Application (2027-2032) & (k units) Table 35. Global Estrogen Sales Volume Share by Application (2021-2026) Table 36. Global Estrogen Sales Volume Share by Application (2027-2032) Table 37. Global Estrogen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Estrogen Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Estrogen Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Estrogen Sales Value Share by Application (2021-2026) Table 41. Global Estrogen Sales Value Share by Application (2027-2032) Table 42. Global Estrogen Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Estrogen Sales by Region (2021-2026) & (k units) Table 44. Global Estrogen Sales Market Share by Region (2021-2026) Table 45. Global Estrogen Sales by Region (2027-2032) & (k units) Table 46. Global Estrogen Sales Market Share by Region (2027-2032) Table 47. Global Estrogen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Estrogen Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Estrogen Sales Value Share by Region (2021-2026) Table 50. Global Estrogen Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Estrogen Sales Value Share by Region (2027-2032) Table 52. Global Estrogen Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Estrogen Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Estrogen Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Estrogen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Estrogen Sales by Country (2021-2026) & (k units) Table 57. Global Estrogen Sales Market Share by Country (2021-2026) Table 58. Global Estrogen Sales by Country (2027-2032) & (k units) Table 59. Global Estrogen Sales Market Share by Country (2027-2032) Table 60. Global Estrogen Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Estrogen Sales Value Market Share by Country (2021-2026) Table 62. Global Estrogen Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Estrogen Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceuticals Company Information Table 65. Teva Pharmaceuticals Business Overview Table 66. Teva Pharmaceuticals Estrogen Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceuticals Estrogen Product Portfolio Table 68. Teva Pharmaceuticals Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Estrogen Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Pfizer Estrogen Product Portfolio Table 73. Pfizer Recent Development Table 74. Bayer Company Information Table 75. Bayer Business Overview Table 76. Bayer Estrogen Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Bayer Estrogen Product Portfolio Table 78. Bayer Recent Development Table 79. Xi'an Sgonek Biological Technology Company Information Table 80. Xi'an Sgonek Biological Technology Business Overview Table 81. Xi'an Sgonek Biological Technology Estrogen Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Xi'an Sgonek Biological Technology Estrogen Product Portfolio Table 83. Xi'an Sgonek Biological Technology Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Estrogen Distributors List Table 87. Estrogen Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Estrogen Product Image Figure 2. Global Estrogen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estrogen Sales Value (2021-2032) & (US$ Million) Figure 4. Global Estrogen Sales (2021-2032) & (k units) Figure 5. Global Estrogen Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Estrogen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Global Estrogen Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Estrogen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Estrogen Sales Volume Share by Type (2021-2032) Figure 14. Global Estrogen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Estrogen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Estrogen Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Obstetrics & Gynecology Clinics Image Figure 19. Others Image Figure 20. Global Estrogen Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Estrogen Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Estrogen Sales Volume Share by Application (2021-2032) Figure 23. Global Estrogen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Estrogen Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Estrogen Sales Value Share by Application (2021-2032) Figure 26. Global Estrogen Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Estrogen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Estrogen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Estrogen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Estrogen Sales Value (2021-2032) & (US$ Million) Figure 31. North America Estrogen Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Estrogen Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Estrogen Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Estrogen Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Estrogen Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Estrogen Sales Value (2021-2032) & (US$ Million) Figure 37. South America Estrogen Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Estrogen Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Estrogen Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Estrogen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Estrogen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Estrogen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Estrogen Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Estrogen Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Pfizer
  • Bayer
  • Xi'an Sgonek Biological Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Estrogen Sales Value (2021-2032)
  4. 1.2.2 Global Estrogen Sales Volume (2021-2032)
  5. 1.2.3 Global Estrogen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Estrogen Market Dynamics
  1. 2.1 Estrogen Industry Trends
  2. 2.2 Estrogen Industry Drivers
  3. 2.3 Estrogen Industry Opportunities and Challenges
  4. 2.4 Estrogen Industry Restraints
3 Estrogen Market by Company
  1. 3.1 Global Estrogen Company Revenue Ranking in 2025
  2. 3.2 Global Estrogen Revenue by Company (2021-2026)
  3. 3.3 Global Estrogen Sales Volume by Company (2021-2026)
  4. 3.4 Global Estrogen Average Price by Company (2021-2026)
  5. 3.5 Global Estrogen Company Ranking (2024-2026)
  6. 3.6 Global Estrogen Company Manufacturing Base and Headquarters
  7. 3.7 Global Estrogen Company Product Type and Application
  8. 3.8 Global Estrogen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Estrogen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Estrogen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Estrogen Market by Type
  1. 4.1 Estrogen Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injection
  4. 4.2 Global Estrogen Sales Volume by Type
  5. 4.2.1 Global Estrogen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Estrogen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Estrogen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Estrogen Sales Value by Type
  9. 4.3.1 Global Estrogen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Estrogen Sales Value by Type (2021-2032)
  11. 4.3.3 Global Estrogen Sales Value Share by Type (2021-2032)
5 Estrogen Market by Application
  1. 5.1 Estrogen Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Obstetrics & Gynecology Clinics
  4. 5.1.3 Others
  5. 5.2 Global Estrogen Sales Volume by Application
  6. 5.2.1 Global Estrogen Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Estrogen Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Estrogen Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Estrogen Sales Value by Application
  10. 5.3.1 Global Estrogen Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Estrogen Sales Value by Application (2021-2032)
  12. 5.3.3 Global Estrogen Sales Value Share by Application (2021-2032)
6 Estrogen Regional Sales and Value Analysis
  1. 6.1 Global Estrogen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Estrogen Sales by Region (2021-2032)
  3. 6.2.1 Global Estrogen Sales by Region: 2021-2026
  4. 6.2.2 Global Estrogen Sales by Region (2027-2032)
  5. 6.3 Global Estrogen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Estrogen Sales Value by Region (2021-2032)
  7. 6.4.1 Global Estrogen Sales Value by Region: 2021-2026
  8. 6.4.2 Global Estrogen Sales Value by Region (2027-2032)
  9. 6.5 Global Estrogen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Estrogen Sales Value (2021-2032)
  12. 6.6.2 North America Estrogen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Estrogen Sales Value (2021-2032)
  15. 6.7.2 Europe Estrogen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Estrogen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Estrogen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Estrogen Sales Value (2021-2032)
  21. 6.9.2 South America Estrogen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Estrogen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Estrogen Sales Value Share by Country, 2025 VS 2032
7 Estrogen Country-level Sales and Value Analysis
  1. 7.1 Global Estrogen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Estrogen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Estrogen Sales by Country (2021-2032)
  4. 7.3.1 Global Estrogen Sales by Country (2021-2026)
  5. 7.3.2 Global Estrogen Sales by Country (2027-2032)
  6. 7.4 Global Estrogen Sales Value by Country (2021-2032)
  7. 7.4.1 Global Estrogen Sales Value by Country (2021-2026)
  8. 7.4.2 Global Estrogen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Estrogen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Estrogen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Estrogen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Estrogen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Estrogen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Estrogen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Estrogen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Estrogen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Estrogen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Estrogen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Estrogen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Estrogen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Estrogen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Estrogen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Estrogen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Estrogen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Estrogen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Estrogen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Estrogen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Estrogen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Estrogen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Estrogen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Estrogen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Estrogen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Estrogen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Estrogen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Estrogen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Estrogen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Estrogen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Estrogen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Estrogen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Estrogen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Estrogen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Estrogen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Estrogen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Estrogen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Estrogen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Estrogen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Estrogen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Estrogen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Estrogen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Estrogen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Estrogen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Estrogen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Estrogen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Estrogen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Estrogen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Estrogen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Estrogen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Estrogen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Estrogen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Estrogen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Estrogen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Estrogen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Estrogen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Estrogen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Estrogen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Estrogen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Estrogen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Estrogen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Estrogen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Estrogen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Estrogen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Estrogen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Estrogen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Estrogen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Estrogen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Estrogen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Estrogen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Estrogen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Estrogen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Estrogen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Estrogen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Estrogen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Estrogen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Estrogen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Estrogen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Estrogen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Estrogen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Estrogen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Estrogen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Estrogen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Estrogen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Estrogen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Estrogen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Estrogen Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Estrogen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Estrogen Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Estrogen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Estrogen Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Xi'an Sgonek Biological Technology
  20. 8.4.1 Xi'an Sgonek Biological Technology Company Information
  21. 8.4.2 Xi'an Sgonek Biological Technology Business Overview
  22. 8.4.3 Xi'an Sgonek Biological Technology Estrogen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Xi'an Sgonek Biological Technology Estrogen Product Portfolio
  24. 8.4.5 Xi'an Sgonek Biological Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Estrogen Value Chain Analysis
  2. 9.1.1 Estrogen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Estrogen Sales Mode & Process
  6. 9.2 Estrogen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Estrogen Distributors
  9. 9.2.3 Estrogen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst